CHLOROTHIAZIDE SODIUM description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

CHLOROTHIAZIDE SODIUM

Sun Pharma Global FZE

Chlorothiazide Sodium for Injection, USPFOR THE PREPARATION OF INTRAVENOUS SOLUTIONS


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CHLOROTHIAZIDE SODIUM DESCRIPTION


2 H75342
CHLOROTHIAZIDE SODIUM








2 H76342
CHLOROTHIAZIDE SODIUM

CLINICAL PHARMACOLOGY








Pharmacokinetics and Metabolism


CHLOROTHIAZIDE SODIUM INDICATIONS AND USAGE






Use in Pregnancy



PRECAUTIONS, Pregnancy

CHLOROTHIAZIDE SODIUM CONTRAINDICATIONS




WARNINGS














PRECAUTIONS, Drug Interactions

PRECAUTIONS

General
























Laboratory Tests


Drug Interactions




Alcohol, barbiturates, or narcotics
 
Antidiabetic drugs - (oral agents and insulin)
 
Other antihypertensive drugs
 
Corticosteroids, ACTH
 
Pressor amines (e.g., norepinephrine)
 
Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine)
 
Lithium
 
Non-steroidal Anti-inflammatory Drugs

Drug/Laboratory Test Interactions


PRECAUTIONS, General

Carcinogenesis, Mutagenesis, Impairment of Fertility




in vitroSalmonella typhimuriumAspergillus nidulans

1

1

Pregnancy


Teratogenic Effects

INDICATIONS AND USAGE

Nonteratogenic Effects:

Nursing Mothers


Pediatric Use


Geriatric Use




WARNINGS

CHLOROTHIAZIDE SODIUM ADVERSE REACTIONS




Body as a Whole:
 
Cardiovascular:
 
Digestive:
 
Hematologic:

Hypersensitivity:

Metabolic:PRECAUTIONS
 
Musculoskeletal:
 
Nervous System/Psychiatric:
 
Skin:

Special Senses:
 
Renal:WARNINGS

Urogenital:

OVERDOSAGE








50

CHLOROTHIAZIDE SODIUM DOSAGE AND ADMINISTRATION












Extravasation must be rigidly avoided. Do not give subcutaneously or intramuscularly.

Directions for Reconstitution



Use aseptic technique. Because chlorothiazide sodium for injection contains no preservative, a fresh solution should be prepared immediately prior to each administration, and the unused portion should be discarded.

HOW SUPPLIED






Storage



DOSAGE AND ADMINISTRATION, Directions for Reconstitution

Caraco Pharmaceutical Laboratories, Ltd.



Sun Pharmaceutical Ind. Ltd.




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - CARTON


NDC 47335-330-40
Chlorothiazide Sodium for Injection, USP
500 mg/vial
STERILE
LYOPHILIZED
FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS
Rx only
One Single Dose Vial
SUN PHARMACEUTICAL INDUSTRIES LTD.
CHLOROTHIAZIDE SODIUM

CHLOROTHIAZIDE SODIUM

CHLOROTHIAZIDE SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:47335-330
Route of Administration INTRAVENOUS DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CHLOROTHIAZIDE SODIUM CHLOROTHIAZIDE 500 mg

Inactive Ingredients

Ingredient Name Strength
mannitol
SODIUM HYDROXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 18 in 1 VIAL, SINGLE-DOSE
2 NDC:47335-330-40 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091546 2011-08-05


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.